OUTCOMES OF SURGICAL TREATMENT OF DRUG RESISTANT EPILEPSY
Article Sidebar
Main Article Content
Abstract
Background. Pharmacoresistant epilepsy (PRE) remains one of the most challenging neurological conditions, often unresponsive to pharmacological therapy. Surgical intervention is considered the most effective treatment option for selected patients.
Objective. This article summarizes current approaches and outcomes of surgical treatment for PRE, highlighting prognostic factors, surgical techniques, neuropsychological outcomes, and quality of life (QoL) considerations.
Methods. A review of contemporary literature was conducted, analyzing prospective and retrospective studies, meta-analyses, and clinical trials evaluating outcomes after anterior temporal lobectomy with amygdalohippocampectomy (ATL+AH), selective amygdalohippocampectomy (SAH), and minimally invasive techniques, including MRI-guided laser interstitial thermal therapy (MgLiTT), stereoelectroencephalography-guided radiofrequency thermocoagulation (SEEG-guided RFTC), and neuromodulation procedures (vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation). Favorable surgical outcomes are strongly associated with concordant neuroimaging and EEG findings, as well as the extent of resection of the epileptogenic zone. ATL+AH remains the gold standard, demonstrating seizure freedom in up to 70–80% of patients, while SAH offers comparable seizure control with improved preservation of neurocognitive functions. Minimally invasive techniques and neuromodulation provide alternative options for patients with multifocal or surgically inaccessible lesions. Neuropsychological assessments indicate that surgery can halt cognitive decline associated with ongoing seizures and improve QoL, although risks of postoperative deficits remain, particularly with left-sided resections. Multiple studies confirm significant postoperative improvement in QoL scores (QOLIE-31), especially in seizure-free patients.
Conclusion. Surgical treatment of PRE is superior to long-term pharmacotherapy in carefully selected patients, providing seizure freedom, stabilization of cognitive functions, and improved QoL. Early identification of pharmacoresistance and timely surgical referral are crucial for optimizing long-term outcomes.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Lamberink HJ, Otte WM, Blümcke I, Braun KPJ, AichholzerM, AmorimI, et al. Seizure outcome anduse of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: A retrospective multicentre cohort study. Lancet Neurol. 2020; 19: 748-757. doi: 10.1016/S1474-4422(20)30220-9
Арешкина И.Г., Сапронова М.Р., Шнайдер Н.А., Народова Е.А., Дмитренко Д.В. Исходы хирургического лечения эпилепсии. Доктор.Ру. 2020; 19(4): 29-34. [Areshkina IG, Sapronova MR, Schnaider NA, Narodova EA, Dmitrenko DV Outcomes of epilepsy surgery. Doctor.Ru. 2020; 19(4): 29-34. (In Russ.)]. doi: 10.31550/1727-2378-2020-19-4-29-34
Edelvik A, Rydenhag B, Olsson I, Flink R, Kumlien E, Källén K, et al. Long-term outcomes of epilepsy surgery in Sweden: Anational prospective and longitudinal study. Neurology. 2013; 81: 1244-1251. doi: 10.1212/WNL.0B013E3182A6CA7B
Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: A randomized trial. JAMA. 2012; 307: 922-930. doi: 10.1001/JAMA.2012.220
Rathore C, Jeyaraj MK, Dash GK, Wattamwar P, Baheti N, Sarma SP, et al. Outcome after seizure recurrence on antiepileptic drug withdrawal following temporal lobectomy. Neurology. 2018; 91: e208-216. doi: 10.1212/WNL.0000000000005820
Subbotina OP, Tibekina LM, Tonyan SN. Clinical diagnostic features and surgical outcomes of mesial temporal lobe epilepsy. Grekov’s Bulletin of Surgery. 2022; 181(3): 91-99. (InRuss.)]. doi:10.24884/0042-4625-2022-181-3-91-99
CharyyevaG, Tibekina LM, SubbotinaOP. Pharmacoresistance in epilepsy and ways for overcoming it (literature review). Vestnik of Saint Petersburg University. Medicine. 2020; 15: 184-197. doi: 10.21638/spbu11.2020.303
Engel J Jr. (2016). What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture. Neurology, 87(23), 2483–2489. https://doi.org/10.1212/WNL.0000000000003407
Téllez-Zenteno JF, Dhar R, Wiebe S. (2005). Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain, 128(5), 1188–1198. https://doi.org/10.1093/brain/awh449
Jobst BC, Cascino GD. (2015). Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA, 313(3), 285–293. https://doi.org/10.1001/jama.2014.17426
Jehi L, Yardi R, Chagin K, et al. (2015). Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysis. Lancet Neurol., 14(3), 283–290. https://doi.org/10.1016/S1474-4422(14)70325-4
Wiebe S, Blume WT, Girvin JP, Eliasziw M. (2001). A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med., 345(5), 311–318. https://doi.org/10.1056/NEJM200108023450501
Josephson CB, Dykeman J, Fiest KM, et al. (2013). Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology, 80(18), 1669–1676. https://doi.org/10.1212/WNL.0b013e3182904f82
Gross RE, Willie JT, Drane DL. (2018). The role of stereotactic laser amygdalohippocampotomy in mesial temporal lobe epilepsy. Neurosurg Clin N Am., 27(1), 37–50. https://doi.org/10.1016/j.nec.2015.08.006
Fisher R, Salanova V, Witt T, et al. (2010). Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia, 51(5), 899–908. https://doi.org/10.1111/j.1528-1167.2010.02536.x
Schramm J, Clusmann H. (2008). Surgery for temporal lobe epilepsy: a European approach. Epilepsia, 49 Suppl 3, 9–17. https://doi.org/10.1111/j.1528-1167.2008.01508.x
Helmstaedter C, Elger CE. (2009). Cognitive outcomes of different surgical approaches in temporal lobe epilepsy. Epileptic Disord., 11(1), 90–98.
Josephson CB, Dykeman J, Fiest KM, et al. (2013). Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology, 80(18), 1669–1676. https://doi.org/10.1212/WNL.0b013e3182904f82
Paglioli E, Palmini A, Paglioli E, et al. (2006). Comparison of anterior temporal lobectomy with amygdalohippocampectomy versus selective amygdalohippocampectomy: postoperative seizure outcome and prognostic factors. Epilepsia, 47(3), 704–712. https://doi.org/10.1111/j.1528-1167.2006.00490.x
Clusmann H, Schramm J, Kral T, et al. (2002). Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg., 97(5), 1131–1141. https://doi.org/10.3171/jns.2002.97.5.1131
Téllez-Zenteno JF, Hernández-Ronquillo L, Moien-Afshari F, Wiebe S. (2010). Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res., 89(2-3), 310–318. https://doi.org/10.1016/j.eplepsyres.2010.02.007
Petrosyan DV, Kopachev DN, Sharkova SM, Kremneva EI, Dragoi OV, Mikhailova EN, et al. Results of surgical treatment of patients with drug-resistant structural temporal lobe epilepsy. Nervous Diseases. 2021; (4): 42-47. (In Russ.)]. doi: 10.24412/2226- 0757-2021-12375
Cramer, J. A., Perrine, K., Devinsky, O., & Bryant-Comstock, L. (1998). Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia, 39(1), 81–88. https://doi.org/10.1111/j.1528-1157.1998.tb01278.x
Cramer, J. A., Perrine, K., Devinsky, O., Bryant-Comstock, L., Meador, K., & Hermann, B. (1998). Development and cross-cultural translations of a 10-item quality of life in epilepsy inventory. Epilepsia, 39(1), 81–88. https://doi.org/10.1111/j.1528-1157.1998.tb01278.x
Devinsky, O., Vickrey, B. G., Cramer, J., Perrine, K., Hermann, B., Meador, K., Hays, R. D., & The QOLIE Development Group. (1995). Development of the quality of life in epilepsy inventory. Epilepsia, 36(11), 1089–1104. https://doi.org/10.1111/j.1528-1157.1995.tb00467.x
Saadi, A., Patenaude, B., Mateen, F. J., & Prasad, K. (2016). Quality of life in epilepsy: A systematic review of the QOLIE-31. Epilepsia, 57(5), 868–874. https://doi.org/10.1111/epi.13372
Vickrey, B. G., Hays, R. D., Engel, J. Jr., Spritzer, K., Rogers, W. H., Rausch, R., Graber, J., Brook, R. H. (1995). Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Neurology, 45(3), 479–486. https://doi.org/10.1212/WNL.45.3.479
Spencer, S. S., Berg, A. T., Vickrey, B. G., Sperling, M. R., Bazil, C. W., Shinnar, S., Langfitt, J. T., Walczak, T. S., Pacia, S., Devinsky, O., & The Epilepsy Surgery Study Group. (2003). Health-related quality of life over time since resective epilepsy surgery. Annals of Neurology, 54(4), 487–494. https://doi.org/10.1002/ana.10698
Ives-Deliperi, V. L., & Butler, J. T. (2017). The impact of epilepsy surgery on quality of life in patients with refractory temporal lobe epilepsy. Epilepsy & Behavior, 73, 20–25. https://doi.org/10.1016/j.yebeh.2017.05.018